NewAmsterdam Pharma Co N.V 10-K for FY2025
NewAmsterdam Pharma Co N.V. (NAMS)
10-K
2026-02-18
For: 2025-12-31
View Original
Added on
April 09, 2026
About this 10-K
NewAmsterdam Pharma Co N.V filed this 10-K on February 18, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $22.5M
- down 50.6% from $45.56M a year earlier
- Net loss
- $203.82M
- compared with a net loss of $241.6M a year earlier
- Diluted EPS
- -$1.72
- compared with -$2.56 a year earlier